CytomX Therapeutics Inc (CTMX)
4.43
-0.07
(-1.56%)
USD |
NASDAQ |
May 03, 16:00
4.69
+0.26
(+5.87%)
After-Hours: 20:00
CytomX Therapeutics Market Cap: 300.01M for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 300.01M |
| May 02, 2024 | 304.75M |
| May 01, 2024 | 347.41M |
| April 30, 2024 | 110.39M |
| April 29, 2024 | 109.03M |
| April 26, 2024 | 107.68M |
| April 25, 2024 | 108.35M |
| April 24, 2024 | 110.39M |
| April 23, 2024 | 113.77M |
| April 22, 2024 | 113.10M |
| April 19, 2024 | 113.10M |
| April 18, 2024 | 117.16M |
| April 17, 2024 | 119.19M |
| April 16, 2024 | 125.96M |
| April 15, 2024 | 133.41M |
| April 12, 2024 | 145.60M |
| April 11, 2024 | 145.60M |
| April 10, 2024 | 142.22M |
| April 09, 2024 | 137.48M |
| April 08, 2024 | 139.51M |
| April 05, 2024 | 139.51M |
| April 04, 2024 | 139.51M |
| April 03, 2024 | 145.60M |
| April 02, 2024 | 144.92M |
| April 01, 2024 | 145.60M |
| Date | Value |
|---|---|
| March 28, 2024 | 147.63M |
| March 27, 2024 | 148.31M |
| March 26, 2024 | 142.89M |
| March 25, 2024 | 144.92M |
| March 22, 2024 | 142.89M |
| March 21, 2024 | 151.70M |
| March 20, 2024 | 153.73M |
| March 19, 2024 | 147.63M |
| March 18, 2024 | 136.80M |
| March 15, 2024 | 140.18M |
| March 14, 2024 | 139.51M |
| March 13, 2024 | 142.22M |
| March 12, 2024 | 145.60M |
| March 11, 2024 | 169.98M |
| March 08, 2024 | 169.30M |
| March 07, 2024 | 173.37M |
| March 06, 2024 | 182.85M |
| March 05, 2024 | 184.20M |
| March 04, 2024 | 185.56M |
| March 01, 2024 | 179.46M |
| February 29, 2024 | 165.92M |
| February 28, 2024 | 170.97M |
| February 27, 2024 | 151.45M |
| February 26, 2024 | 111.06M |
| February 23, 2024 | 100.97M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
71.55M
Minimum
Oct 27 2023
672.32M
Maximum
May 12 2020
270.32M
Average
291.66M
Median
Dec 29 2021
Market Cap Benchmarks
| Ocular Therapeutix Inc | 917.03M |
| Bristol-Myers Squibb Co | 89.17B |
| ACADIA Pharmaceuticals Inc | 2.809B |
| Cytokinetics Inc | 6.723B |
| Calidi Biotherapeutics Inc | 7.001M |
Market Cap Related Metrics
| PS Ratio | 3.232 |
| Price | 4.43 |
| Earnings Yield | -0.45% |